DÄ internationalArchiveReferences

Original article

Lead Poisoning Due to Adulterated Marijuana in Leipzig

Dtsch Arztebl Int 2008; 105(44): 757-62. DOI: 10.3238/arztebl.2008.0757

Busse, F P; Fiedler, G M; Leichtle, A; Hentschel, H; Stumvoll, M

1. Suplido ML, Ong CN: Lead exposure among small-scale battery recyclers, automobile radiator mechanics, and their children in manila. The Philippines Environ Res 2000; 82: 231–8.
2. Patrick L: Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment. Altern Med Rev 2006; 11: 2–22.
3. Hogervorst J, Plusquin M, Vangronsveld J et al.: House dust as possible route of environmental exposure to cadmium and lead in the adult general population. Environ Res 2007; 103: 30–7.
4. Busse F, Omidi L, Timper K, Leichtle A, Windgassen M, Kluge E, Stumvoll M: Lead poisoning due to adulterated marijuana. N Engl J Med 2008; 358: 1641–2.
5. Schrenk D: Blei. In: Seeger R, Neumann HG: Giftlexikon. Stuttgart: Deutscher Apotheker Verlag 2005; 514.
6. Needleman H: Lead poisoning. Annu Rev Med 2004; 55: 209–22.
7. Hu H, Shih R, Rothenberg S, Schwartz BS: The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect 2007; 115: 455–62.
8. Piomelli S: Childhood lead poisoning. Pediatr Clin North Am 2002; 49: 1285–304, vii.
9. Warren MJ, Cooper JB, Wood SP, Shoolingin-Jordan PM: Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends Biochem Sci 1998; 23: 217–21.
10. Valentine JL, Baloh RW, Browdy BL et al.: Subclinical effects of chronic increased lead absorption – a prospective study. Part IV. Evaluation of heme synthesis effects. J Occup Med 1982; 24: 120–5.
11. Lanphear BP, Hornung R, Khoury Jet al.: Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005; 113: 894–9.
12. Marsden PA: Increased body lead burden – cause or consequence of chronic renal insufficiency? N Engl J Med 2003; 348: 345–7.
13. Papanikolaou NC, Hatzidaki EG, Belivanis S, Tzanakakis GN, Tsatsakis AM: Lead toxicity update. A brief review. Med Sci Monit 2005; 11: RA329–36.
14. Kosnett MJ, Wedeen RP, Rothenberg SJ et al.: Recommendations for medical management of adult lead exposure. Environ Health Perspect 2007; 115: 463–71.
15. Staessen JA, Bulpitt CJ, Fagard R, Lauwerys RR, Roels H, Thijs L, Amery A: Hypertension caused by low-level lead exposure: Myth or fact? J Cardiovasc Risk 1994; 1: 87–97.
16. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA: An Epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 2002; 16: 123–31.
17. Lustberg M, Silbergeld E: Blood lead levels and mortality. Arch Intern Med 2002; 162: 2443–9.
18. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM: Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 2006; 114: 1538–41.
19. Fu H, Boffetta P: Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med 1995; 52: 73–81.
20. Pearce JM: Burton's line in lead poisoning. Eur Neurol 2007; 57: 118–9.
21. Burton H: On a remarkable effect on the human gums produced by the absorption of lead. Med Chir Trans 1840; 23: 63–79.
22. HBM-Kommission: Aktualisierung der Referenzwerte für Blei, Cadmium und Quecksilber im Blut und im Urin von Erwachsenen. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2003; 46: 1112–3.
23. Gracia RC, Snodgrass WR: Lead toxicity and chelation therapy. Am J Health Syst Pharm 2007; 64: 45–53.
24. Patrick L: Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev 2006; 11: 114–27.
25. DGAUM, Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V.: Leitlinien der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V. (DGAUM). AWMF online: http://leitlinien.net/2005
e1. Bellinger DC, Bellinger AM: Childhood lead poisoning: the torturous path from science to policy. J Clin Invest 2006; 116: 853–7.
e2. Montes, Santiago J: Goya, Fortuny, Van Gogh, Portinari: lead poisoning in painters across three centuries. Rev Clin Esp 2006; 206: 30–2.
e3. Friedman T, Westreich M, Lurie DJ, Golik A: Rembrandt – aging and sickness: a combined look by plastic surgeons, an art researcher and an internal medicine specialist. Isr Med Assoc J 2007; 9: 67–71.
e4. Reiter C: Beethovens Todesursachen und seine Locken – Eine forensisch-toxikologische Recherche. Wiener Beethoven-Gesellschaft. Mitteilungsblatt 2008.
e5. Rabinowitz PM, Siegel MD: Acute inhalation injury. Clin Chest Med 2002; 23: 707–15.
e6. Baker RA: Temperature distribution inside a burning cigarette. Nature 1974; 247: 406.
e7. Cheong JH, Bannon D, Olivi L, Kim Y, Bressler J: Different mechanisms mediate uptake of lead in a rat astroglial cell line. Toxicol Sci 2004; 77: 334–40.
e8. Staessen JA, Lauwerys RR, Buchet JP et al.: Impairment of renal function with increasing blood lead concentrations in the general population. The cadmibel study group. N Engl J Med 1992; 327: 151–6.
e9. Yu CC, Lin JL, Lin-Tan DT: Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol 2004; 15: 1016–22.
e10. Schwartz J: Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health 1995; 50: 31–7.
e11. Rousseau MC, Parent ME, Nadon L, Latreille B, Siemiatycki J: Occupational exposure to lead compounds and risk of cancer among men: a population-based case-control study. Am J Epidemiol 2007; 166: 1005–14.
e12. Masoodi M, Zali MR, Ehsani-Ardakani MJ: Abdominal pain due to lead-contaminated opium: a new source of inorganic lead poisoning in Iran. Arch Iran Med 2006; 9: 72–5.
e13. Beattie AD, Briggs JD, Canavan JS, Doyle D, Mullin PJ, Watson AA: Acute lead poisoning: five cases resulting from self-injection of lead and opium. Q J Med 1975; 44: 275–84.
e14. Fitzsimons EJ, Dagg JH: Lead poisoning in a drug addict; the intravenous injection of suppository extracts. Br J Clin Pract 1982; 36: 284–5.
e15. Algora M, Martin-Castillo A, Zabala P, Fernandez MN: Lead poisoning due to drug addiction: a new source of poisoning with clinical interest and important epidemiological consequences. An Med Interna 1989; 6: 483–5.
e16. D'Alessandro, Gandolfo L, Macri A et al.: An unusual mechanism of lead poisoning. Presentation of a case. Recenti Prog Med 1989; 80: 140–1.
e17. Antonini G, Palmieri G, Millefiorini E, Spagnoli LG, Millefiorini M: Lead poisoning during heroin addiction. Ital J Neurol Sci 1989; 10: 105–8.
e18. Teggi A, Lanzalone CM, De Rinaldis MLet al.: A case of lead poisoning in a drug addict. Observations on etiopathogenetic peculiarities. Clin Ter 1988; 124: 223–6. MEDLINE
e19. Molina Manzano J, Martin del Yerro JL, Fernandez Alvaro P, Martin Scapa A, Cano A, Fernandez Fuertes I: Lead poisoning and drug addiction. Rev Clin Esp 1987; 181: 117–8. MEDLINE
e20. Parras F, Patier JL, Ezpeleta C: Lead-contaminated heroin as a source of inorganic-lead intoxication. N Engl J Med 1987; 316: 755. MEDLINE
e21. Norton RL, Burton BT, McGirr J: Blood lead of intravenous drug users. J Toxicol Clin Toxicol 1996; 34: 425–30. MEDLINE
e22. From the Centers for Disease Control: Lead poisoning associated with intravenous-methamphetamine use – Oregon, 1988. JAMA 1990; 263: 797–8. MEDLINE